Daniel's Substack

Home
Archive
About
A personalized, targeted, multi-factorial approach shows promise for reversal of cognitive decline
ReCODE: Reversal of Cognitive Decline - 100 Patients. Image illustration by Harriet Lee-Merrion, November 23, 2022, the New Yorker.
 • 
Daniel Segercrantz

July 2023

Repost: Approaching risk, objectives, and interventions
In Frameworks and Essentials for optimizing health and Longevity, I describe how longevity consists of lifespan and healthspan, i.e. how long and well…
Lowering homocysteine and adequate omega-3 status for slowing cognitive decline
VITACOG demonstrates adequate omega-3 status and lowering homocysteine with B-vitamins to slow brain atrophy and cognitive decline
 • 
Daniel Segercrantz

March 2023

Measures of inflammation in atherosclerotic cardiovascular disease
A deeper look into evidence in support of measuring hsCRP as means of assessing cardovascular risk
 • 
Daniel Segercrantz
Notes on notions
"Probability is orderly opinion..."
 • 
Daniel Segercrantz

January 2023

Magnesium supplementation and cardiovascular disease
Part one of questioning convictions on magnesium
 • 
Daniel Segercrantz
Conflicting clinical outcomes on the pharmacological use of omega-3s for reducing the risk of adverse cardiovascular events
First in serie of trying to evaluate the risk to reward ratio of supplementing and pharmacologically using omega-3 fatty acids to reduce disease risk
 • 
Daniel Segercrantz

December 2022

High dietary protein intake and renal health
One of the inevitabilities of aging seems to be a progressive degradation of kidney function as measured by the estimated glomerular filtration rate…
 • 
Daniel Segercrantz
On triglycerides
How do triglycerides relate to ASCVD risk?
 • 
Daniel Segercrantz

November 2022

Lowdown on salt and potassium
Diving into the literature on salt and potassium intake
 • 
Daniel Segercrantz
Vaguely on salt
Edited and republished #5
 • 
Daniel Segercrantz

October 2022

Bearish on conventional Risk Score calculators, Bullish on early interventions (part II)
Exposure time to risk factors is of major importance in the assessment of total risk for major adverse cardiac events and mortality, something…
 • 
Daniel Segercrantz
© 2024 Daniel Segercrantz
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture